EVOLVE-MI

Objective

The EVOLVE-MI trial is a pragmatic randomized multicenter trial of evolocumab administered very early to reduce the risk of cardiovascular events in patients hospitalized with acute myocardial infarction.

National Clinical Trial (NCT) Number: 05284747

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/study/NCT05284747

Research Study Categories

• Clinical Trials and Health Care Delivery Studies

Specialties

• Cardiology